Patent of SX-fraction Registered in Canada Following Japan and the US as Therapeutic Agent for Polycystic Ovary Syndrome(PCOS)
PCOS is a leading cause of infertility， affecting 5-10 % of women of reproductive age and believed to be closely associated with insulin resistance or metabolic syndrome. SX-fraction is known to help increase insulin sensitivity balancing out the endocrine system. As a consequence， PCOS patients taking SX-fraction report that they start ovulating periodically and even become pregnant naturally. A number of such clinical cases have been reported already. Also， PCOS patients often repeat miscarriage. However， after taking SX-fraction， the risk for miscarriage is reduced. Therefore， SX-fraction may be useful for those PCOS patients who have not achieved goals of conventional therapy. It is also appreciated by patients as a safe and natural substance with no side effects or a risk for secondary disease.*
(*) OHSS (Ovarian Hyperstimulation Syndrome) exhibits complications such as swollen ovaries， ascites or pleural effusion， a condition often caused by taking fertility drugs repeatedly.